LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Viridian Reports Positive Phase 3 REVEAL-1 Results For Elegrobart In Thyroid Eye Disease; But Stock Plunges 3/30/2026 7:48:50 AM
  • Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 12/5/2025 7:04:25 AM
  • Viridian Therapeutics Q3 Net Loss $28.2 Mln Or $0.34/Shr Vs Loss $58.8 Mln Or $0.88/Shr Last Year 11/5/2025 7:49:50 AM
  • Wedbush Is Lowering Viridian Therapeutics, Inc. (VRDN) FY 26 Estimate To -3.46 From -3.27 10/27/2025 11:05:10 PM
  • Wedbush Is Lowering Viridian Therapeutics, Inc. (VRDN) Q4 26 Estimate To -0.82 From -0.66 10/27/2025 11:04:45 PM
  • Wedbush Is Lowering Viridian Therapeutics, Inc. (VRDN) Q3 26 Estimate To -0.96 From -0.87 10/27/2025 11:04:14 PM
  • Wedbush Is Cutting Viridian Therapeutics, Inc. (VRDN) Q2 26 Estimate To -0.90 From -0.88 10/27/2025 11:04:03 PM
  • Wedbush Is Raising Viridian Therapeutics, Inc. (VRDN) Q1 26 Estimate To -0.79 From -0.85 10/27/2025 11:03:48 PM
  • Wedbush Is Cutting Viridian Therapeutics, Inc. (VRDN) FY 25 Estimate To -2.84 From -2.83 10/27/2025 11:03:37 PM
  • Wedbush Is Increasing Viridian Therapeutics, Inc. (VRDN) Q4 25 Estimate To -0.12 From -0.83 10/27/2025 11:03:26 PM
  • Viridian Therapeutics Announces Pricing Of 11.425 Mln Common Shares At $22/Shr 10/21/2025 11:31:04 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap